Browsing by Author "Ciftci, Eda Derle"

Now showing 1 - 4 of 4

Depression, Anxiety, Burden and Coping Mechanisms in The Family Caregivers of Alzheimer's Dementia Patients in A Turkish Sample
(2014) Aki, Ozlem Erden; Kaya, Yildiz; Isikli, Sedat; Kibaroglu, Seda; Ciftci, Eda Derle; Can, Ufuk Anik; https://orcid.org/0000-0002-3964-268X; https://orcid.org/0000-0003-2122-1016; AAJ-2956-2021; AAI-8830-2021
HEADACHE CHARACTERISTICS IN GERIATRIC AGE GROUP ACCORDING TO ICHD-3 BETA VERSION
(2018) Ciftci, Eda Derle; Toprak, Munire Kilinc; Yildirim, Irem
Introduction: The aim of this study was to screen patients aged >= 65 years admitted to the Baskent University Hospital Neurology Polyclinic between 2011 and 2013 and classify them according to the International Classification of Headache Disorders, 3rd edition. Materials and Method: In total, 175 patients (126 females and 49 males) were screened. First, they were separated into primary and secondary headache groups, and the subgroup headache types were then defined within these groups according to the International Classification of Headache Disorders, 3rd edition; then, the concurrence of accompanying chronic diseases were examined. Results: In the primary headache group, 21.1% of the patients had migraine, 39.4% had tension-type headache, and 51% had trigeminal neuralgia; in the secondary headache group, 24.2% of the patients had headache attributed to hypertension, 18.2% had headache attributed to temporal arteritis, 18.2% had headache attributed to cervical pathology, and 12.1% had headache attributed to intracranial mass. Conclusion: This study was conducted to detect the most commonly seen headache types in geriatric population, and the results of this study are important in terms of increasing awareness of the evaluation of both primary and secondary headaches in geriatric patients. Because the study was conducted with a less patient population, it is important in terms of more accurately demonstrating the factors constituting the etiology of headache in this patient group.
Vaccination in Individuals with Multiple Sclerosis - Part I
(2023) Cinar, Bilge Piri; Tuncer, Asli; Bilge, Nuray; Bunul, Sena Destan; Gozubatik Celik, Rabia Gokcen; Ciftci, Eda Derle; Genc, Gencer; Karaman, Bedriye; Kilic, Ahmet Kasim; Sariteke, Alp; Seferoglu, Meral; Tiftikcioglu, Bedile Irem; Tunc, Abdulkadir; Uncu, Gulgun; Yavas, Irfan; Yetkin, Mehmet Fatih; Efendi, Husnu; Siva, Aksel; 0000-0001-6900-4702
Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions should be made by considering the disease process and the drugs used by the patient. Since vaccination can be performed at every stage of life, from childhood to adulthood, immune system activity, except where it is characteristic of the vaccine, should be reviewed in patients with MS. In this review, the applications of different vaccines in individuals with MS are discussed in two separate sections.
Voltage gated calcium channel antibody-related neurological diseases
(2015) Bekircan-Kurt, Can Ebru; Ciftci, Eda Derle; Kurne, Asli Tuncer; Anlar, Banu; 25789302
Voltage gated calcium channel (VGCC) antibodies are generally associated with Lambert-Eaton myasthenic syndrome. However the presence of this antibody has been associated with paraneoplastic as well as nonparaneoplastic cerebellar degeneration. Most patients with VGCC-antibody-positivity have small cell lung cancer (SCLC). Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disease of the presynaptic part of the neuromuscular junction. Its classical clinical triad is proximal muscle weakness, areflexia and autonomic dysfunction. Fifty to sixty percent of LEMS patients have a neoplasia, usually SCLC. The co-occurrence of SCLC and LEMS causes more severe and progressive disease and shorter survival than non-paraneoplastic LEMS. Treatment includes 3,4 diaminopyridine for symptomatic purposes and immunotherapy with prednisolone, azathioprine or intravenous immunoglobulin in patients unresponsive to 3,4 diaminopyridine. Paraneoplastic cerebellar degeneration (PCD) is a syndrome characterized with severe, subacute pancerebellar dysfunction. Serum is positive for VGCC antibody in 41%-44% of patients, usually with the co-occurrence of SCLC. Clinical and electrophysiological features of LEMS are also present in 20%-40% of these patients. Unfortunately, PCD symptoms do not improve with immunotherapy. The role of VGCC antibody in the immunopathogenesis of LEMS is well known whereas its role in PCD is still unclear. All patients presenting with LEMS or PCD must be investigated for SCLC.